James McCord, MD
Internal Medicine · Detroit, MINPI 1437227980
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Beckman Coulter, Inc. at 34.4% of the total. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $921.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beckman Coulter, Inc.$11K
- Roche Diagnostics Corporation$10K
- Polymedco, LLC$6K
- Roche Diagnostics International Ltd$5K
- Novo Nordisk$282
- E.r. Squibb & Sons, L.L.C.$125
- plus $240 from 5 others
Across 5 payments — averaging $92,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$460K
What the payments were for
- Consulting fees$19,19658%
- Speaking & faculty fees$11,10833%
- Travel & lodging$1,4704%
- Food & beverage$1,3254%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beckman Coulter, Inc. | 8 | $11,396 |
| Roche Diagnostics Corporation | 14 | $10,013 |
| Polymedco, LLC | 1 | $6,000 |
| Roche Diagnostics International Ltd | 3 | $5,108 |
| Novo Nordisk | 4 | $282 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Pfizer | 1 | $122 |
| Quidel Corporation | 1 | $50 |
| Lantheus Medical Imaging, Inc. | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Recor Medical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CD cobas Reagents$7,085
- ACCESS 2$5,746
- DXI 800$5,746
- DXI 600$5,746
- cobas 6800 System$2,308
- POC ACCU-CHEK Inform II Meters, Strips and Assessories$2,200
- RDI Research$1,750
- Elecsys Troponin T Gen 5 STAT$1,050
- POC cobas Liat Analyzer, Assays, Controls and Accessories$348
- POC cobas Accutrend Meters, Strips and Assessories$124
- VYNDAQEL$122
How this compares
$33,164 in reported general payments places this provider in the 95th percentile of 4,567 internal medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 84 | $128,937 |
| XareltoRivaroxaban | 15 | $23,469 |
| Ezetimibe | 76 | $2,399 |
| Rosuvastatin Calcium | 100 | $2,226 |
| Atorvastatin Calcium | 135 | $1,830 |
| Metoprolol Succinate | 99 | $1,434 |
| Warfarin Sodium | 53 | $990 |
| Metoprolol Tartrate | 79 | $820 |
| Lisinopril | 91 | $806 |
| Losartan Potassium | 59 | $802 |
| Carvedilol | 48 | $641 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 31 | $499 |
| Nifedipine ErNifedipine | 16 | $473 |
| Pravastatin Sodium | 33 | $470 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 18 | $469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $122 | $128,93784 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Detroit
- Saroj NeupaneDetroit$373K
- David StocktonDetroit$306K
- Mervin WolffDetroit$182K
- Philip KuriakoseDetroit$143K
- Ivan HansonDetroit$137K
- Omeralfaroug AdamDetroit$124K
- Jalal MaghfourDetroit$81K
- Ravish ParekhDetroit$68K
- Dipenkumar ModiDetroit$64K
- Garen WolffDetroit$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.